Cleared Traditional

K031177 - DIASTAT ANTI-B2 GLYCOPROTEIN 1 IGM, MODEL FBGP 100M (FDA 510(k) Clearance)

Jun 2003
Decision
66d
Days
Class 2
Risk

K031177 is an FDA 510(k) clearance for the DIASTAT ANTI-B2 GLYCOPROTEIN 1 IGM, MODEL FBGP 100M. This device is classified as a System,test,antibodies,b2 - Glycoprotein I (b2 - Gpi) (Class II - Special Controls, product code MSV).

Submitted by Axis-Shield Diagnostics, Ltd. (Dundee, GB). The FDA issued a Cleared decision on June 19, 2003, 66 days after receiving the submission on April 14, 2003.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5660.

Submission Details

510(k) Number K031177 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 14, 2003
Decision Date June 19, 2003
Days to Decision 66 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement

Device Classification

Product Code MSV — System,test,antibodies,b2 - Glycoprotein I (b2 - Gpi)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5660